IGNACIO RAMIREZ: Open Payments
NPI 1962536086 · PORT NECHES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 39 payments from 14 companies in 2025. Trend: 2023 $51 · 2024 $157 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $136 |
| ABBVIE INC. | 5 | $101 |
| PFIZER INC. | 5 | $86 |
| Antares Pharma, Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $52 |
| Dexcom, Inc. | 2 | $45 |
| Corcept Therapeutics | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
Products named: Kerendia, Wegovy, NURTEC ODT, XYOSTED, QULIPTA, MOUNJARO, UBRELVY, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
